Incidence of symptomatic lymphocele and lymphadenectomy in patients with ovarian cancer who treated with TachoSil (fibrinogen/thrombin): A rerospective pilot study
Latest Information Update: 16 May 2017
At a glance
- Drugs Fibrinogen/thrombin (Primary)
- Indications Surgical blood loss
- Focus Adverse reactions
- 16 May 2017 New trial record